Otofarma SpA (MIL:OTO) Change In Receivables: €-0.10 Mil (TTM As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.54
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Change In Receivables?

Otofarma SpA MIL:OTO -3.05% 16 Change In Receivables is €-0.10 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's change in receivables for the quarter that ended in Dec. 2024 was €-0.10 Mil. It means Otofarma SpA's Accounts Receivable increased by €0.10 Mil from Dec. 2023 to Dec. 2024 .

Otofarma SpA's change in receivables for the fiscal year that ended in Dec. 2024 was €-0.10 Mil. It means Otofarma SpA's Accounts Receivable increased by €0.10 Mil from Dec. 2023 to Dec. 2024 .

Otofarma SpA's Accounts Receivable for the quarter that ended in Dec. 2024 was €3.54 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Otofarma SpA's Days Sales Outstanding for the six months ended in Dec. 2024 was 42.46.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Otofarma SpA's liquidation value for the six months ended in Dec. 2024 was €0.17 Mil.

Otofarma SpA  (MIL:OTO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Otofarma SpA's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3.536/15.2*91
=42.46

2. In Ben Graham's calculation of liquidation value, Otofarma SpA's accounts receivable are only considered to be worth 75% of book value:

Otofarma SpA's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2.52-5.082+0.75 * 3.536+0.5 * 0.157
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Change In Receivables Related Terms

Otofarma SpA Change In Receivables Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Change In Receivables Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Change In Receivables
-0.76 -0.10

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Change In Receivables -0.76 -0.10
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €-0.10 Mil mean?
Otofarma SpA (MIL:OTO) has a Change In Receivables of €-0.10 Mil as of Dec. 2024. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Otofarma SpA and its competitors.
Is Otofarma SpA's Change In Receivables too high?
Otofarma SpA's current Change In Receivables is €-0.10 Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Change In Receivables compare to ABT and SYK?
Otofarma SpA's Change In Receivables of €-0.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Otofarma SpA and its competitors. Otofarma SpA's current Change In Receivables is €-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Change In Receivables of €-0.10 Mil. The current Change In Receivables is €-0.10 Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Change In Receivables is €-0.10 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.54
Price